In Vitro and In Vivo Evaluation of Commercially Available Fibrin Gel as a Carrier of Alendronate for Bone Tissue Engineering

<div>Histologic morphology of the new bone at 8 weeks after implantation. In the central area, newly formed bone was more mature in the fibrin/ALN gel-implanted group than in the fibrin gel group. The arrow indicates the newly formed bone containing woven bone and lamella. Arrow head indicates the defect marginal site. Hb, host bone; Nb, new bone. Scale bar: 500 <i>μ</i>m.</div>

BioMed Research International

fig8

Figure 8

Figure 8: In Vitro and In Vivo Evaluation of Commercially Available Fibrin Gel as a Carrier of Alendronate for Bone Tissue Engineering 